P4ML, a Future 100 UAE company, in collaboration with DHA (Dubai Health Authority) and Fakeeh University Hospital, has launched a transformative 5-year multi-omic study to advance personalized health and fitness. Aligned with the Dubai Fitness Challenge—which engaged 2.75 million participants in 2024 and anticipates 15 million participants over the next five years—this initiative aims to screen over 2 million volunteers as part of the ‘OMIC-Assist’ longitudinal study.
Revolutionizing Personalized Health and Fitness with MultiOMIC Technology
This cross-sectional population study will deliver tailored fitness and nutrition strategies, uncover disease risk factors, and empower participants with actionable insights for long-term health improvement. By harnessing multi-omic science, the study provides real-world evidence and a personalized approach to health, helping participants achieve their wellness goals while contributing to a healthier global community.
Patrick J. Moloney, Founder of P4ML, explained, “This study is not just about improving an individual’s health—it’s about pioneering a new global standard for personalized medicine”. He further stated, “Core research will include single-cell omics, gut microbiome analysis, lipid biomarkers, epigenetic and proteomic profiles. Using advanced technologies, such as mass spectrometry, we aim to provide a true systems biology approach to human health and well-being. A multi-omic perspective can enable researchers and biopharma to better understand disease biology to develop new diagnostic and therapies for a wide range of diseases. This study in the UAE provides for a greater diversity of datasets for validating and replicate findings from other world leading biobanking initiatives’.
P4ML and Fakeeh University Hospital Lead the World’s Largest Health Study
The “OMIC-Assist” study, targeting over 2 million participants, will become the world’s largest decentralized health research project. The study incorporates a trusted research environment, ensuring participant data is secured and ethically managed while enabling groundbreaking discoveries. In conjunction with Empower Data-Governance, the study will deploy quantum technologies. These measures highlight the project’s commitment to the highest standards of privacy and security.
Dr. Mohaymen Abdelghany, CEO of Fakeeh University Hospital, stated, “Our collaboration with P4ML brings a transformative approach to patient care. By integrating advanced science with robust data security, we are enabling healthier communities and reshaping the future of medicine.”
Dubai Solidifies its Position as a Global Leader in Healthcare Innovation
This study reinforces Dubai’s leadership in merging cutting-edge technology with health. It exemplifies Dubai’s role in driving innovation to create impactful healthcare solutions. Participants will gain real-world benefits, including personalized insights into fitness, nutrition, and wellness, contributing to healthier lifestyles and a deeper understanding of their health.
Also Read: Cemplicity Expands to UAE, Driving Real-Time Patient Insights.
Patrick J. Moloney, Founder of P4ML, commented, “This multi-omic study reflects Dubai’s dedication to innovative global partnerships that deliver meaningful, transformative healthcare solutions and the study has the ability to establish a future pre-competitive pharma consortium.” By integrating personalized health strategies, world-class data security, and global impact into one initiative, this study sets a new standard for healthcare innovation leveraging the power of secondary data analysis to generate impactful insights and future patient registries. Participants are invited to join this landmark study and experience tailored insights that could shape the future of their health and well-being.
